DOC monthly performance report
Monthly DOC research: returns, drawdown, relative strength, seasonality, and key stats.
DOC monthly report
—
Key takeaways
- Healthpeak Properties (DOC) closed August 2026 at $21.79, down 0.18% for the month and +26.76% over the trailing 12 months.
- Year-to-date, DOC is +35.51%, outperforming the S&P 500 which has returned +12.89% YTD.
- The stock is trading +19.45% versus its 200-day moving average ($18.24), a bullish technical signal.
- Over the past three years, DOC has underperformed the S&P 500 by −69.65%, with a relative strength index reading of 59.4.
- Win rate over the trailing 39 months stands at 53.8% — 21 positive months versus 18 negative months.
Healthpeak Properties ended August 2026 at $21.79, posting a monthly return of −0.18%. The S&P 500 returned +3.05% over the same window, leaving relative performance at −3.23%.
The current quarter stands at +3.77% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +19.45% versus the 200-day moving average ($18.24).
Year-to-date, DOC is +35.51% against SPY +12.89%, a gap of +22.62%. The stock is currently −5.05% below its 52-week high, with maximum 3-year drawdown at −31.75%.
| Period | DOC | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.79% | −0.20% | +0.99% |
| 1 Week | −4.51% | +3.90% | −8.42% |
| 1 Month | −0.18% | +3.05% | −3.23% |
| 3 Months | +34.76% | +7.11% | +27.64% |
| 6 Months | +28.78% | +10.70% | +18.09% |
| YTD | +35.51% | +12.89% | +22.62% |
| 12 Months | +26.76% | +22.58% | +4.18% |
| 3 Years | +2.64% | +72.29% | −69.65% |
| Rank | Month | Return |
|---|---|---|
| #1 | May 2026 | +18.36% |
| #2 | Dec 2023 | +14.58% |
| #3 | Mar 2024 | +12.01% |
| #4 | Jun 2026 | +11.98% |
| #5 | Jul 2024 | +11.33% |
| Rank | Month | Return |
|---|---|---|
| #1 | Oct 2023 | −14.84% |
| #2 | Apr 2025 | −12.38% |
| #3 | Dec 2025 | −11.40% |
| #4 | Sep 2023 | −11.26% |
| #5 | Feb 2024 | −9.12% |
| Quarter | Return |
|---|---|
| Q2 2025 | −13.69% |
| Q3 2025 | +9.39% |
| Q4 2025 | −14.02% |
| Q1 2026 | +3.97% |
| Q2 2026 | +30.68% |
| Q3 2026 (QTD) | +3.77% |
| Year | Return |
|---|---|
| 2023 | −23.33% |
| 2024 | −0.37% |
| 2025 | −18.35% |
| 2026 | +40.99% |
| Metric | Value |
|---|---|
| 52-Week High | $22.95 (2026-07-28) |
| 52-Week Low | $15.71 (2025-12-23) |
| Current Price | $21.79 |
| 200-Day Moving Average | $18.24 |
| Price vs 200DMA | +19.45% |
| 3-Year Maximum Drawdown | −31.75% (2025-12-23) |
| Current Drawdown from 52W High | −5.05% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 59.4 |
| 3-Year Excess Return vs S&P 500 | −69.65% |
| RS Peak | 100 (Aug 2023) |
| RS Trough | 47.1 (Apr 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was DOC's return for this report period?
DOC returned −0.18% in the latest monthly window ending 2026-08-05.
Has DOC outperformed SPY year to date?
YTD DOC: +35.51% vs SPY: +12.89%.
What is DOC's 12-month return?
+26.76% over the trailing 12 months.
Is DOC above or below its 200-day moving average?
Price is +19.45% versus 200DMA ($18.24).
What is the maximum drawdown in the 3-year window?
−31.75% on 2025-12-23.